Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03005639
Title ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Inova Health Care Services
Indications

melanoma

Therapies

Cobimetinib + Vemurafenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST